Collaboration with Large Research Infrastructures

How are strategic partnerships with large research infrastructures developing?
You can watch videos about our collaboration with EATRIS-CZ, BBMRI.cz and CZECRIN on our YouTube channel.

What would not have been without the National Institute for Cancer Research

Explore both the published and unpublished outcomes achieved by the National Institute for Cancer Research thanks to its outstanding research teams.

Podcast In-Amongst the Cells

You can also listen to our original science podcast In-Amongst the Cells on Spotify and Apple Podcasts.
a

3nodes

Prague, Brno, Olomouc

5

research programmes

11

research institutes

71

research teams

1shared goal

progress in the fight against cancer

Details

About us

Research of cancers represents about 25% of all biomedical research in the Czech Republic. It is an area that has a long tradition in our country and its current results are, in international comparison, above the average.

Details

Newsletter subscription

If you would like to subscribe to our newsletter, please email us HERE.

News and announcements

14. 4. 2026

New CREATIC Labs Bring ATMPs for Rare Diseases

On April 8, new laboratories of the Centre of Excellence CREATIC, dedicated to the research, development, and manufacturing of advanced therapy medicinal products (ATMPs), were opened in the renovated pavilion at the University Campus Bohunice of Masaryk University. Teams from the NICR have also made a significant contribution to their development.
Líbí se?
Read more
10. 4. 2026

AFO 2026: Documentary on Colorectal Cancer and Discussion with NICR

Join us at AFO 2026 and don’t miss the documentary “André Is an Idiot”—a story about a man who is dying because he underestimated prevention and did not undergo a colonoscopy in time. Representatives of NICR will also take part in the subsequent discussion.
Líbí se?
Read more

Collaboration

In addition to several large European and Czech scientific infrastructures, the National Institute for Cancer Research will also cooperate with various university hospitals, pharmaceutic or biotechnological companies, patient organisations, and other partners.

Details